SCHEMBL3357789

SCHEMBL3357789

COc1ccc(C2Cc3cc(O)c(O)cc3OC2=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.57
ALOX12 P18054 2/20 0.57
KMT2A Q03164 2/20 0.54
POLB P06746 1/20 0.54
RECQL P46063 1/20 0.54
ALDH1A1 P00352 6/20 0.51
CYP19A1 P11511 2/20 0.46
HPGD P15428 2/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP1B1 Q16678 1/20 0.44
KDM1A O60341 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
MAP2K3 P46734 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069508 0.86 ALDH1A1 (0.59) ALOX15ALOX12KMT2APOLBRECQL
SCHEMBL28907445 0.85 ALDH1A1 (0.50) ALOX15ALOX12KMT2APOLBRECQL
SCHEMBL572237 0.85 ALOX12 (0.52) ALOX15ALOX12KMT2APOLBRECQL
SCHEMBL705946 0.80 CYP19A1 (0.52) KMT2APOLBRECQLALDH1A1CYP19A1
SCHEMBL14389073 0.79 ALDH1A1 (0.52) KMT2APOLBRECQLALDH1A1CYP19A1
SCHEMBL28555018 0.77 CYP19A1 (0.55) KMT2AALDH1A1CYP19A1HPGDMEN1
SCHEMBL2071246 0.77 RECQL (0.49) ALOX15ALOX12KMT2APOLBRECQL
SCHEMBL11263779 0.75 ALDH1A1 (0.64) KMT2APOLBRECQLALDH1A1CYP19A1
SCHEMBL2530020 0.74 KMT2A (0.50) KMT2APOLBRECQLALDH1A1HPGD
SCHEMBL10562731 0.73 ALOX15 (1.00) ALOX15ALOX12KMT2APOLBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 ALOX15 3682/4885ALOX12 3429/4885KMT2A 2121/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 ALOX15 3682/4885ALOX12 3429/4885KMT2A 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.